Hannah Jacqueline Szapary, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Finger Injuries | 1 | 2022 | 138 | 0.750 |
Why?
|
| End Stage Liver Disease | 1 | 2022 | 326 | 0.610 |
Why?
|
| Cartilage, Articular | 1 | 2023 | 1085 | 0.510 |
Why?
|
| Osteoarthritis | 1 | 2023 | 1047 | 0.500 |
Why?
|
| Hip Fractures | 1 | 2022 | 966 | 0.460 |
Why?
|
| Liver Diseases | 1 | 2022 | 1268 | 0.450 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2022 | 1376 | 0.400 |
Why?
|
| Fractures, Bone | 1 | 2022 | 2008 | 0.350 |
Why?
|
| Cholesterol | 2 | 2020 | 2879 | 0.170 |
Why?
|
| Fingers | 1 | 2022 | 503 | 0.170 |
Why?
|
| Chondrocytes | 1 | 2023 | 790 | 0.150 |
Why?
|
| Creatinine | 1 | 2022 | 1848 | 0.140 |
Why?
|
| Morbidity | 1 | 2022 | 1743 | 0.140 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 1501 | 0.140 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2017 | 88 | 0.130 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2020 | 327 | 0.130 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 485 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2023 | 1919 | 0.130 |
Why?
|
| Orthopedics | 1 | 2022 | 872 | 0.110 |
Why?
|
| Orthopedic Procedures | 1 | 2022 | 1250 | 0.100 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 655 | 0.100 |
Why?
|
| Reoperation | 1 | 2022 | 4215 | 0.100 |
Why?
|
| Astrocytes | 1 | 2020 | 1303 | 0.100 |
Why?
|
| Microglia | 1 | 2020 | 1309 | 0.100 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2021 | 1351 | 0.090 |
Why?
|
| Cholesterol, HDL | 1 | 2017 | 1795 | 0.090 |
Why?
|
| Cytokines | 1 | 2023 | 7219 | 0.080 |
Why?
|
| Myocardium | 1 | 2020 | 4639 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2022 | 78293 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 15539 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2022 | 5763 | 0.050 |
Why?
|
| Risk Factors | 3 | 2022 | 72413 | 0.050 |
Why?
|
| Neurons | 1 | 2020 | 9287 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2022 | 15341 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 8302 | 0.040 |
Why?
|
| Humans | 8 | 2023 | 746070 | 0.040 |
Why?
|
| High-Density Lipoproteins, Pre-beta | 1 | 2017 | 6 | 0.040 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2020 | 548 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2020 | 1559 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15010 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 1491 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2020 | 830 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 2074 | 0.030 |
Why?
|
| Dependovirus | 1 | 2017 | 701 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 29072 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2020 | 4514 | 0.020 |
Why?
|
| Adult | 1 | 2022 | 214969 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 40505 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6420 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16652 | 0.010 |
Why?
|
| Macrophages | 1 | 2017 | 5648 | 0.010 |
Why?
|
| Liver | 1 | 2017 | 7371 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6456 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 11842 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 53219 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 164222 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 214419 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57552 | 0.010 |
Why?
|
| Male | 2 | 2020 | 351098 | 0.010 |
Why?
|
| Female | 2 | 2020 | 382129 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 80065 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 166308 | 0.000 |
Why?
|